Vol. 17 No. 2 (2024)

• In Memory of Professor N.N. Tupitsyn

  76-81

  • PDF (Russian)

EXPERIMENTAL STUDIES

• Xenotransplantation of Human Hematopoietic Stem Cells into NBSGW Mice: A Basic Model for Preclinical Development of Gene Therapy Approaches

  Alena Igorevna Shakirova, I.N. Gaponenko, Ya.V. Komarova, O.S. Epifanovskaya, D.A. Senichkina, V.S. Sergeev, A.R. Muslimov, A.V. Onopchenko, E.V. Shchelina, S.A. Osipova, O.G. Bredneva, M.L. Vasyutina, Ya.G. Toropova, K.V. Lepik, M.O. Popova, I.S. Moiseev, A.D. Kulagin

  82-93

  • PDF_2024-17-2_82-93 (Russian)

REVIEWS

• Plasma Cell Tumors in Hematological Classifications of 2022: WHO-HAEM5 (WHO, 5th edition) and ICC (International Consensus Classification). A Clinician’s View

  Sergei Vyacheslavovich Semochkin

  94-108

  • PDF_2024-17-2_94-108 (Russian)

• PET/CT in Hematological Malignancies: What Has Been Achieved and What Remains to Be Done

  Aleksei Sergeevich Subbotin, A.I. Pronin, T.M. Geliashvili, P.E. Tulin, T.S. Basova, B.M. Khakulova, G.S. Tumyan, A.A. Semenova

  109-128

  • PDF_2024-17-2_109-128 (Russian)

• Plasmablastic Lymphoma and Plasmablastic Myeloma: А Diagnostic Dilemma (Literature Review)

  Mariya Vladimirovna Melnikova, A.M. Kovrigina

  129-140

  • PDF_2024-17-2_129-140 (Russian)

LYMPHOID TUMORS

• The Role of Polymorphic Variants of Р450 Cytochrome Genes as well as Genes GSTP1 and MDR1 in Toxic Complications of Program Drug Chemotherapy for Classical Hodgkin Lymphoma

  Yana Yurevna Shebunyaeva

  141-153

  • PDF_2024-17-2_141-153 (Russian)

• Diagnostic Potential of Regulatory Non-Coding Protein RNAs in Chronic Lymphocytic Leukemia

  Igor Alekseevich Olkhovskii

  154-165

  • PDF_2024-17-2_154-165 (Russian)

• CD20-Positive B-Lymphocytes in the Reactive Tumor Microenvironment as an Independent Immunohistochemical Prognostic Factor in Nodular Sclerosis Classical Hodgkin Lymphoma

  Maksim Sergeevich Minaev

  166-172

  • PDF_2024-17-2_166-172 (Russian)

• Therapy Optimization in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Efficacy and Safety of the R-SD-EPOCH ± HDMTX Program Under Single-Center Non-Randomized Prospective Clinical Trial (Preliminary Results)

  Marat Albertovich Mingalimov

  173-179

  • PDF_2024-17-2_173-179 (Russian)

MYELOID TUMORS

• Treatment of Aggressive Systemic Mastocytosis and Mast Cell Leukemia. Literature Review and Case Reports

  Vsevolod Gennadevich Potapenko, E.V. Morozova

  180-194

  • PDF_2024-17-2_180-194 (Russian)

RARE HEMATOLOGICAL TUMORS AND SYNDROMES

• Paroxysmal Nocturnal Hemoglobinuria and Primary Myelofibrosis as an Extremely Rare Combination of Clonal Hematological Diseases: A Literature Review and Two Clinical Case Reports

  Anna Leonidovna Neverova

  195-203

  • PDF_2024-17-2_195-203 (Russian)

CLINICAL TRIALS

• Risk Factors for Relapses of Perianal Infectious Complications in Patients with Hematological Malignancies: Results of a Single-Center Prospective Trial

  Svetlana Vitalevna Shtyrkova, K.I. Danishyan, E.N. Parovichnikova

  204-212

  • PDF_2024-17-2_204-212 (Russian)

Supplement

• III scientific-practical conference conference “Modern approaches to the diagnosis and treatment of hematological diseases”

  • Приложение (Russian)